Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026)
Green Thumb Industries (GTBIF) reported Depreciation & Amortization (CF) of $32.4 million for Q1 2026, up 10.21% on a YoY basis from $29.4 million in Q1 2025, and down 42.41% quarter-over-quarter from $56.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $32.4 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 10.21% year-over-year to $32.4 million; the trailing twelve-month figure through Mar 2026 stood at $148.5 million (up 29.26% YoY), and the FY2025 full-year result was $145.4 million, up 28.48% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $32.4 million, down from $56.3 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $56.3 million in Q4 2025, with the low at $23.0 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $28.7 million across 5 years, with a median of $27.8 million in 2024.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) rose 0.15% — and 2025, when it surged 94.37%.
- Green Thumb Industries' Depreciation & Amortization (CF) stood at $25.0 million in 2022, then advanced by 9.89% to $27.4 million in 2023, then gained by 5.58% to $29.0 million in 2024, then surged by 94.37% to $56.3 million in 2025, then slumped by 42.41% to $32.4 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $32.4 million (Q1 2026), $56.3 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 32.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.41 Mn |
| Mar 31, 2026 | 32.41 Mn |
| Dec 31, 2025 | 56.29 Mn |
| Dec 31, 2025 | 56.29 Mn |
| Sep 30, 2025 | 30.08 Mn |
| Sep 30, 2025 | 30.08 Mn |
| Jun 30, 2025 | 29.67 Mn |
| Jun 30, 2025 | 29.67 Mn |
| Mar 31, 2025 | 29.41 Mn |
| Mar 31, 2025 | 29.41 Mn |
| Dec 31, 2024 | 28.96 Mn |
| Dec 31, 2024 | 28.96 Mn |
| Sep 30, 2024 | 28.49 Mn |
| Sep 30, 2024 | 28.49 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Mar 31, 2024 | 27.78 Mn |
| Mar 31, 2024 | 27.78 Mn |
| Dec 31, 2023 | 27.43 Mn |
| Dec 31, 2023 | 27.43 Mn |